Notch1-Gli1 Axis Reprograms Macrophage Polarization and Promotes Hepatic Inflammation and Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis
The American Journal of Pathology · 2026-06 · 196 (6) · 1272-1286
DOI: 10.1016/j.ajpath.2026.03.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2026-06. Verfasst von Haihua Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Zinc Finger Protein GLI1, Receptor, Notch1, Macrophages, Liver Cirrhosis. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Wuhan University, National Major Science and Technology Projects of China, Health Commission of Hubei Province.
Abstract (Originalsprache)
There has been extensive interest in metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced stage, metabolic dysfunction-associated steatohepatitis (MASH). Although several studies have highlighted the importance of hepatocyte Notch signaling in MASH-related liver fibrosis, the role of macrophage Notch signaling in MASH-related fibrosis has been less explored. This study found that Notch1 signaling in hepatic macrophages was significantly activated in a high-fat diet (HFD)-induced mouse model of MASH. Depletion of myeloid Notch1 led to a significant reduction in disease progression in this HFD-induced MASH model, as evidenced by reduced hepatic inflammation, steatosis, and fibrosis in HFD-fed, myeloid-specific Notch1 knockout mice. Intriguingly, disruption of Notch1 suppressed the expression of Gli1, a key transcription factor in the Hedgehog signaling pathway, and promoted M2-like macrophage polarization in the injured liver. Furthermore, the Notch1 deletion-mediated effects-namely, M2 macrophage polarization and the reduction in hepatic steatosis and fibrosis-were reversed by treatment with the Hedgehog agonist SAG in HFD-fed mice. In vitro experiments further demonstrated that Notch1 deletion promoted a shift in macrophage polarization toward the M2 phenotype by inhibiting Gli1 expression. Collectively, these findings identify the Notch1-Gli1 axis as a novel regulator of macrophage polarization, hepatic inflammation, steatosis, and fibrosis in MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Anatomy and Histology Embryology, Jinzhou Medical University, Jinzhou, China; Department of Anatomy, Youjiang Medical University for Nationalities, Baise, China.
- Department of Physiology, Wuhan University TaiKang Medical School (School of Basic Medical Sciences), Wuhan, China; Xianning Medical College, Hubei University of Science and Technology, Xianning, China. Electronic addre…
- Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, China; Xianning Medical College, Hubei University of Science and Technology, Xianning, China. Electronic address: jianxia@whu.edu.cn.
Förderung
- Wuhan University
- National Major Science and Technology Projects of China
- Health Commission of Hubei Province
- National Research Council of Science and Technology
Zitieren
APA
Chen, H., Yang, M., Tu, X., Li, J., Li, C., & Xia, J. (2026). Notch1-Gli1 Axis Reprograms Macrophage Polarization and Promotes Hepatic Inflammation and Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis. The American Journal of Pathology, 196(6), 1272-1286. https://doi.org/10.1016/j.ajpath.2026.03.001
Vancouver
Chen H, Yang M, Tu X, Li J, Li C, Xia J. Notch1-Gli1 Axis Reprograms Macrophage Polarization and Promotes Hepatic Inflammation and Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis. The American Journal of Pathology. 2026;196(6):1272-1286. doi:10.1016/j.ajpath.2026.03.001
BibTeX
@article{Chen2026,
author = {Chen, Haihua and Yang, Min and Tu, Xiaopeng and Li, Jiahui and Li, Changyong and Xia, Jian},
title = {Notch1-Gli1 Axis Reprograms Macrophage Polarization and Promotes Hepatic Inflammation and Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis},
journal = {The American Journal of Pathology},
year = {2026},
volume = {196},
number = {6},
pages = {1272--1286},
doi = {10.1016/j.ajpath.2026.03.001}
}
EUVIMED